Recombinetics, Inc. (RCI)
Transforming Public Health by Engineering Animals for Biomedicine & Food Production .
Recombinetics has developed and acquired a portfolio of proprietary genome engineering technologies it uses to make precise modifications to the genomes of several livestock species. The results are animals with enhanced value for biomedicine and agricultural markets. First products are pigs that exhibit human heart disease. Customers are academic scientists, pharmaceutical and medical device companies, and CROs that want a consistent model.